• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Variability in PET quantitation within a multicenter consortium.多中心协作组内 PET 定量的可变性。
Med Phys. 2010 Jul;37(7):3660-6. doi: 10.1118/1.3455705.
2
Use of a Qualification Phantom for PET Brain Imaging in a Multicenter Consortium: A Collaboration Between the Pediatric Brain Tumor Consortium and the SNMMI Clinical Trials Network.使用资格体模进行多中心联盟的 PET 脑成像:小儿脑瘤联盟与 SNMMI 临床试验网络之间的合作。
J Nucl Med. 2019 May;60(5):677-682. doi: 10.2967/jnumed.118.219998. Epub 2018 Dec 7.
3
Repeatability of SUV measurements in serial PET.PET 中 SUV 测量的重复性。
Med Phys. 2011 May;38(5):2629-38. doi: 10.1118/1.3578604.
4
Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures.评价多中心试验中 FDG PET/CT 研究协调策略:扫描仪验证体模和数据分析程序的比较。
Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1507-15. doi: 10.1007/s00259-013-2465-0. Epub 2013 Jun 11.
5
Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT.影响 PET/CT 定量示踪剂摄取的方差和偏差的仪器因素。
Med Phys. 2010 Nov;37(11):6035-46. doi: 10.1118/1.3499298.
6
Defining a radiotherapy target with positron emission tomography.用正电子发射断层扫描定义放射治疗靶区。
Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1272-82. doi: 10.1016/j.ijrobp.2004.06.254.
7
Automated Quantitative Analysis of American College of Radiology PET Phantom Images.美国放射学会PET体模图像的自动定量分析
J Nucl Med Technol. 2019 Sep;47(3):249-254. doi: 10.2967/jnmt.118.221317. Epub 2019 Apr 24.
8
Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.局部晚期乳腺癌俯卧位与仰卧位18F-FDG-PET的比较:模型研究与初步临床研究
Med Phys. 2015 Jul;42(7):3801-13. doi: 10.1118/1.4921363.
9
Comparison of fluorine-18 and bromine-76 imaging in positron emission tomography.正电子发射断层扫描中氟-18与溴-76成像的比较。
Eur J Nucl Med. 1999 Jul;26(7):758-66. doi: 10.1007/s002590050447.
10
Quantitative PET/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom.基于核医学与分子影像学会临床试验网络肿瘤学临床模拟体模的定量 PET/CT 扫描仪性能特征描述。
J Nucl Med. 2015 Jan;56(1):145-52. doi: 10.2967/jnumed.114.148056. Epub 2014 Dec 18.

引用本文的文献

1
Usefulness of a new anthropomorphic phantom simulating the chest and abdomen regions in PET tests.一种模拟PET检查中胸部和腹部区域的新型人体模型的效用。
Ann Nucl Med. 2025 Mar;39(3):303-312. doi: 10.1007/s12149-024-02007-2. Epub 2024 Dec 7.
2
Nuclear medicine radiomics in digestive system tumors: Concept, applications, challenges, and future perspectives.消化系统肿瘤中的核医学影像组学:概念、应用、挑战及未来展望
View (Beijing). 2023 Dec;4(6). doi: 10.1002/VIW.20230032. Epub 2023 Jul 28.
3
Toward Quantitative Multisite Preclinical Imaging Studies in Acute Myocardial Infarction: Evaluation of the Immune-Fibrosis Axis.面向急性心肌梗死的定量多部位临床前成像研究:免疫-纤维化轴的评估。
J Nucl Med. 2024 Feb 1;65(2):287-293. doi: 10.2967/jnumed.123.266526.
4
A Review on the Use of Imaging Biomarkers in Oncology Clinical Trials: Quality Assurance Strategies for Technical Validation.影像学标志物在肿瘤临床试验中的应用综述:技术验证的质量保证策略。
Tomography. 2023 Oct 17;9(5):1876-1902. doi: 10.3390/tomography9050149.
5
Quality improvements in radiation oncology clinical trials.放射肿瘤学临床试验中的质量改进。
Front Oncol. 2023 Jan 26;13:1015596. doi: 10.3389/fonc.2023.1015596. eCollection 2023.
6
Assessing the variability and correlation between SUV and ADC parameters of head and neck cancers derived from simultaneous PET/MRI: A single-center study.评估源于头颈部癌同步 PET/MRI 的 SUV 和 ADC 参数的变异性和相关性:一项单中心研究。
J Appl Clin Med Phys. 2023 May;24(5):e13928. doi: 10.1002/acm2.13928. Epub 2023 Feb 10.
7
A review of harmonization strategies for quantitative PET.定量 PET 调谐策略综述。
Ann Nucl Med. 2023 Feb;37(2):71-88. doi: 10.1007/s12149-022-01820-x. Epub 2023 Jan 6.
8
Understanding the importance of quality control and quality assurance in preclinical PET/CT imaging.了解临床前PET/CT成像中质量控制和质量保证的重要性。
EJNMMI Phys. 2022 Oct 31;9(1):77. doi: 10.1186/s40658-022-00503-w.
9
Method to determine the statistical technical variability of SUV metrics.确定SUV指标统计技术变异性的方法。
EJNMMI Phys. 2022 Jun 6;9(1):40. doi: 10.1186/s40658-022-00470-2.
10
Harmonization of [C]raclopride brain PET images from the HR+ and HRRT: method development and validation in human subjects.来自HR+和HRRT的[C]雷氯必利脑PET图像的标准化:方法开发及在人体受试者中的验证
EJNMMI Phys. 2022 Apr 13;9(1):27. doi: 10.1186/s40658-022-00457-z.

本文引用的文献

1
PET/CT Assessment of Response to Therapy: Tumor Change Measurement, Truth Data, and Error.正电子发射断层扫描/计算机断层扫描(PET/CT)评估治疗反应:肿瘤变化测量、真实数据和误差。
Transl Oncol. 2009 Dec;2(4):223-30. doi: 10.1593/tlo.09223.
2
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.18F-FDG PET 和 PET/CT:欧洲核医学协会肿瘤 PET 成像操作指南:第 1.0 版。
Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):181-200. doi: 10.1007/s00259-009-1297-4.
3
Interim positron emission tomography scan in multi-center studies: optimization of visual and quantitative assessments.多中心研究中的中期正电子发射断层扫描:视觉和定量评估的优化。
Leuk Lymphoma. 2009 Nov;50(11):1748-9. doi: 10.3109/10428190903308049.
4
Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy.18F-FDG PET定量及CT测量肿瘤治疗反应的观察者间再现性评估。
J Nucl Med. 2009 Nov;50(11):1760-9. doi: 10.2967/jnumed.109.063321. Epub 2009 Oct 16.
5
Repeatability of 18F-FDG PET in a multicenter phase I study of patients with advanced gastrointestinal malignancies.18F-FDG PET在晚期胃肠道恶性肿瘤患者多中心I期研究中的重复性
J Nucl Med. 2009 Oct;50(10):1646-54. doi: 10.2967/jnumed.109.063347. Epub 2009 Sep 16.
6
Qualification of PET scanners for use in multicenter cancer clinical trials: the American College of Radiology Imaging Network experience.用于多中心癌症临床试验的正电子发射断层扫描(PET)扫描仪的资质认定:美国放射学会影像网络的经验
J Nucl Med. 2009 Jul;50(7):1187-93. doi: 10.2967/jnumed.108.057455. Epub 2009 Jun 12.
7
From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.从RECIST到PERCIST:实体瘤中PET反应标准的不断演变的考量
J Nucl Med. 2009 May;50 Suppl 1(Suppl 1):122S-50S. doi: 10.2967/jnumed.108.057307.
8
Standards for PET image acquisition and quantitative data analysis.PET图像采集与定量数据分析标准。
J Nucl Med. 2009 May;50 Suppl 1:11S-20S. doi: 10.2967/jnumed.108.057182. Epub 2009 Apr 20.
9
The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials.荷兰在多中心试验中进行氟代脱氧葡萄糖(FDG)全身PET研究的标准化和定量协议。
Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2320-33. doi: 10.1007/s00259-008-0874-2. Epub 2008 Aug 15.
10
Variability of lesion detectability and standardized uptake value according to the acquisition procedure and reconstruction among five PET scanners.
Ann Nucl Med. 2008 Jul;22(6):543-8. doi: 10.1007/s12149-008-0152-1. Epub 2008 Aug 1.

多中心协作组内 PET 定量的可变性。

Variability in PET quantitation within a multicenter consortium.

机构信息

Department of Radiology, Division of Nuclear Medicine, Children's Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Boston, Massachusetts 02115, USA.

出版信息

Med Phys. 2010 Jul;37(7):3660-6. doi: 10.1118/1.3455705.

DOI:10.1118/1.3455705
PMID:20831073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2905446/
Abstract

PURPOSE

The purpose of this study was to evaluate the variability in quantitation of positron emission tomography (PET) data acquired within the context of a multicenter consortium.

METHODS

PET quantitation phantoms designed by American Association of Physicists in Medicine/ Society of Nuclear Medicine Task Group 145 were sent to the ten member sites of the Pediatric Brain Tumor Consortium (PBTC), a NIH-funded research consortium investigating the biology and therapies for brain tumors in children. The phantoms were water-filled cylinders (18.6 cm inside height and 20.4 cm inside diameter) based on the standard ACR phantom with four small, "hot" cylinders of varying diameters (8, 12, 16, 25 mm, all with 38 mm height), consisting of an equilibrium mixture of 68Ge/68Ga in an epoxy matrix. At each site, the operator added the appropriate amount of 18F to the water in the background in order to attain a feature-to-background ratio of roughly 4:1. The phantom was imaged and reconstructed as if it were a brain PET scan for the PBTC. An approximately 12 mm circular region of interest (ROI) was placed over each feature and in a central area in the background. The mean and maximum pixel values for each ROI were requested from local sites in units of activity concentration (Bq/ml) and the standard uptake value (SUV) (g/mL) based on bodyweight. The activity concentration was normalized by the decay-corrected known activity concentration for the features, and reported as the absolute recovery coefficient (RC). In addition, central analyses were performed by two observers

RESULTS

The ten sites successfully imaged the phantom within 5 months and submitted the quantitative results and the phantom image data to the PBTC Operations and Biostatistics Center. The local site-based and central analyses yielded similar mean values for RC. Local site-based SUV measurements of the hot cylindrical features yielded greater variability than central analysis (COV range of 29.9%-42.8% compared to 7.7%-23.2%). Correcting for miscalculations in the local site reported SUVs substantially reduced the variation to levels similar to the central analysis (COV range of 8.8%-18.4%) and also led to the local sites providing a similar mean of the SUV values to those from the central analysis. In the central analysis, the use of mean SUV in place of maximum SUV for an ROI of fixed size substantially reduced the variation in the SUV values (COV ranges of 7.7%-11.3% vs. 9.3%-23.2%).

CONCLUSIONS

Based on this investigation, a SUV variability in the range of 10%-25% due solely to instrument and analysis factors can be expected in the context of a multicenter consortium if a central reading is used and quality assurance and quality control procedures are followed. The overall SUV variability can be expected to be larger than this due to biological and protocol factors.

摘要

目的

本研究旨在评估在多中心研究联盟背景下进行正电子发射断层扫描(PET)数据定量的可变性。

方法

由美国医学物理学家协会/核医学协会任务组 145 设计的 PET 定量体模被发送到儿科脑肿瘤联盟(PBTC)的十个成员站点,这是一个由美国国立卫生研究院资助的研究联盟,旨在研究儿童脑肿瘤的生物学和治疗方法。体模是基于标准 ACR 体模的充满水的圆柱体(内高 18.6 厘米,内径 20.4 厘米),有四个不同直径的小“热”圆柱体(8、12、16、25 毫米,均高 38 毫米),由环氧树脂基质中的 68Ge/68Ga 平衡混合物组成。在每个站点,操作员在背景水中添加适量的 18F,以使特征与背景的比率大致为 4:1。该体模被成像并重建为 PBTC 的脑 PET 扫描。在每个特征和背景中央的大约 12 毫米圆形感兴趣区(ROI)中放置一个 ROI。从当地站点以活性浓度(Bq/ml)和标准摄取值(SUV)(g/ml)为单位请求每个 ROI 的平均和最大像素值,基于体重。活性浓度通过对特征的衰减校正已知活性浓度进行归一化,并报告为绝对恢复系数(RC)。此外,由两名观察者进行中心分析。

结果

十个站点在 5 个月内成功地对体模成像,并向 PBTC 运营和生物统计学中心提交了定量结果和体模图像数据。本地站点和中央分析的 RC 均值相似。本地站点基于 SUV 测量的热圆柱形特征的变异性大于中央分析(COV 范围为 29.9%-42.8%,而 7.7%-23.2%)。对本地站点报告的 SUV 中错误计算的校正大大降低了变化,使其与中央分析水平相似(COV 范围为 8.8%-18.4%),并使本地站点提供与中央分析相似的 SUV 值平均值。在中央分析中,对于固定大小的 ROI,使用平均 SUV 代替最大 SUV,可大大降低 SUV 值的变化(COV 范围为 7.7%-11.3%与 9.3%-23.2%)。

结论

根据这项研究,如果使用中央读取并遵循质量保证和质量控制程序,则可以预期在多中心研究联盟背景下,由于仪器和分析因素引起的 SUV 变化在 10%-25%范围内。由于生物学和方案因素,整体 SUV 变化可能会更大。